Results 271 to 280 of about 48,575 (332)

Unexpected Increase in Bone Mineral Density With Rapamycin and Low-Dose Naltrexone: A Case Report of a 52-Year-Old Woman With Osteopenia. [PDF]

Cureus
Britton A, Harinath G, Morgan S, Zalzala S.   +3 more
europepmc   +1 more source

Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails.

JAMA Netw Open
Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA.   +7 more
europepmc   +1 more source

Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Letter]. [PDF]

Drug Des Devel Ther
Wu L, Hu J, Yao P.
europepmc   +1 more source

Assessing the comparative effectiveness of ECHO and coaching implementation strategies in a jail/provider MOUD implementation trial. [PDF]

Implement Sci
Molfenter T, Vechinski J, Kim JS, Zhang J, Meng L, Tveit J, Madden L, Taxman FS.   +7 more
europepmc   +1 more source

Impact of Intracellular Proteins on μ-Opioid Receptor Structure and Ligand Binding. [PDF]

J Phys Chem B
Scott CE, Juechter LA, Rocha J, Jones LD, Outten B, Aishman TD, Ivers AR, Shields GC.   +7 more
europepmc   +1 more source

Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults.

JAMA Health Forum
Hwang JH, Laiteerapong N, Huang ES, Kim DD.   +3 more
europepmc   +1 more source